TH9 cells in skin disorders

Seminars in Immunopathology

Volumn 39, Issue 1, 2017, Pages 47-54

  Clark, Rachael A ^a   Schlapbach, Christoph ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Allergic contact dermatitis; Atopic dermatitis; Candida albicans; Cutaneous; Cutaneous T cell lymphoma; IL 9; Inflammation; Interleukin 9; Psoriasis; Skin; Skin homing; Skin resident; T helper cell subsets; T helper cells; T helper type 9 cells; Th9 cells

Indexed keywords

ALLERGEN; INTERLEUKIN 9;

ATOPIC DERMATITIS; CELL HOMING; CUTANEOUS T CELL LYMPHOMA; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN; SKIN ALLERGY; SKIN DISEASE; SKIN INFECTION; T LYMPHOCYTE; TH9 CELL; ADAPTIVE IMMUNITY; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HELPER CELL; IMMUNOLOGY; IMMUNOTHERAPY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN DISEASES; T LYMPHOCYTE SUBPOPULATION;

ADAPTIVE IMMUNITY; ALLERGENS; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; INTERLEUKIN-9; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; SKIN DISEASES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84997817410     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-016-0607-8     Document Type: Review

References (69)

1. Kaplan MH, Hufford MM, Olson MR (2015) The development and in vivo function of T helper 9 cells. Nat Rev Immunol 15(5):295–307
2. Schlapbach C, Gehad A, Yang C, Watanabe R, Guenova E et al (2014) Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med 6(219):219ra8
3. Licona-Limon P, Henao-Mejia J, Temann AU, Gagliani N, Licona-Limon I et al (2013) Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 39(4):744–757
4. Tan C, Aziz MK, Lovaas JD, Vistica BP, Shi G et al (2010) Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J Immunol 185(11):6795–6801
5. Richard AC, Tan C, Hawley ET, Gomez-Rodriguez J, Goswami R et al (2015) The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. J Immunol 194(8):3567–3582
6. Ying S, Meng Q, Kay AB, Robinson DS (2002) Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy 32(6):866–871
7. Wilhelm C, Turner JE, Van Snick J, Stockinger B (2012) The many lives of IL-9: a question of survival? Nat Immunol 13(7):637–641
8. Vivier E, van de Pavert SA, Cooper MD, Belz GT (2016) The evolution of innate lymphoid cells. Nat Immunol 17(7):790–794
9. Schmitt E, Klein M, Bopp T (2014) Th9 cells, new players in adaptive immunity. Trends Immunol 35(2):61–68
10. Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W et al (2012) Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 18(8):1248–1253
11. Wong MT, Ong DE, Lim FS, Teng KW, McGovern N et al (2016) A high-dimensional atlas of human T cell diversity reveals tissue-specific trafficking and cytokine signatures. Immunity 45(2):442–456
12. Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka K et al (2006) The vast majority of CLA+ T cells are resident in normal skin. J Immunol 176(7):4431–4439
13. Nalleweg N, Chiriac MT, Podstawa E, Lehmann C, Rau TT et al (2015) IL-9 and its receptor are predominantly involved in the pathogenesis of UC. Gut 64(5):743–755
14. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F et al (2012) Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484(7395):514–518
15. Netea MG, Marodi L (2010) Innate immune mechanisms for recognition and uptake of Candida species. Trends Immunol 31(9):346–353
16. Netea MG, Brown GD, Kullberg BJ, Gow NA (2008) An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6(1):67–78
17. Sehra S, Yao W, Nguyen ET, Glosson-Byers NL, Akhtar N et al (2015) TH9 cells are required for tissue mast cell accumulation during allergic inflammation. J Allergy Clin Immunol 136(2):433–440 e1
18. Chen CY, Lee JB, Liu B, Ohta S, Wang PY et al (2015) Induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy. Immunity 43(4):788–802
19. Conti HR, Gaffen SL (2015) IL-17-mediated immunity to the opportunistic fungal pathogen Candida albicans. J Immunol 195(3):780–788
20. Alves de Medeiros AK, Lodewick E, Bogaert DJ, Haerynck F, Van Daele S et al (2016) Chronic and invasive fungal infections in a family with CARD9 deficiency. J Clin Immunol 36(3):204–209
21. Marehbian J, Arrighi HM, Hass S, Tian H, Sandborn WJ (2009) Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease. Am J Gastroenterol 104(10):2524–2533
22. Lopes JP, Stylianou M, Nilsson G, Urban CF (2015) Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells. Sci Rep 5:12287
23. Nieto-Patlan A, Campillo-Navarro M, Rodriguez-Cortes O, Munoz-Cruz S, Wong-Baeza I et al (2015) Recognition of Candida albicans by Dectin-1 induces mast cell activation. Immunobiology 220(9):1093–1100
24. Trevisan E, Vita F, Medic N, Soranzo MR, Zabucchi G et al (2014) Mast cells kill Candida albicans in the extracellular environment but spare ingested fungi from death. Inflammation 37(6):2174–2189
25. Tsunemi Y, Kadono T, Saeki H, Kikuchi K, Tamaki K et al (2010) Secondary cutaneous candidiasis with eosinophilia. J Dermatol 37(2):175–178
26. Vultaggio A, Lombardelli L, Giudizi MG, Biagiotti R, Mazzinghi B et al (2008) T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis. Microbes Infect 10(2):166–174
27. Louahed J, Zhou Y, Maloy WL, Rani PU, Weiss C et al (2001) Interleukin 9 promotes influx and local maturation of eosinophils. Blood 97(4):1035–1042
28. Gounni AS, Gregory B, Nutku E, Aris F, Latifa K et al (2000) Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 96(6):2163–2171
29. Hong CH, Chang KL, Wang HJ, Yu HS, Lee CH (2015) IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: a plausible mechanism of IL-9R in atopic dermatitis. J Dermatol Sci 78(3):206–214
30. Erwig LP, Gow NA (2016) Interactions of fungal pathogens with phagocytes. Nat Rev Microbiol 14(3):163–176
31. Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET et al (2013) Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest 123(11):4641–4653
32. Staudt V, Bothur E, Klein M, Lingnau K, Reuter S et al (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33(2):192–202
33. Yao W, Zhang Y, Jabeen R, Nguyen ET, Wilkes DS et al (2013) Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38(2):360–372
34. Niedbala W, Besnard AG, Nascimento DC, Donate PB, Sonego F et al (2014) Nitric oxide enhances Th9 cell differentiation and airway inflammation. Nat Commun 5:4575
35. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H et al (2014) TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol 15(7):676–686
36. Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT et al (2013) The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol 14(12):1294–1301
37. Skon CN, Lee JY, Anderson KG, Masopust D, Hogquist KA et al (2013) Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat Immunol 14(12):1285–1293
38. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W et al (2008) IL-4 inhibits TGF-beta-induced Foxp 3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9(12):1347–1355
39. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A et al (2008) Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9(12):1341–1346
40. Watanabe R, Gehad A, Yang C, Scott LL, Teague JE et al (2015) Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Transl Med 7(279):279ra39
41. Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD et al (2010) TGF-beta induces IL-9 production from human Th17 cells. J Immunol 185(1):46–54
42. Clark RA (2015) Resident memory T cells in human health and disease. Sci Transl Med 7(269):269rv1
43. Gittler JK, Shemer A, Suarez-Farinas M, Fuentes-Duculan J, Gulewicz KJ et al (2012) Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 130(6):1344–1354
44. Ma L, Xue HB, Guan XH, Shu CM, Zhang JH et al (2014) Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin Exp Immunol 175(1):25–31
45. Ciprandi G, De Amici M, Giunta V, Marseglia A, Marseglia G (2013) Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis. Pediatr Dermatol 30(2):222–225
46. Olivry, T., D. Mayhew, J.S. Paps, K.E. Linder, C. Peredo, et al., Early Activation of Th2/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions. J Invest Dermatol 2016.
47. Namkung JH, Lee JE, Kim E, Park GT, Yang HS et al (2011) An association between IL-9 and IL-9 receptor gene polymorphisms and atopic dermatitis in a Korean population. J Dermatol Sci 62(1):16–21
48. Gomez-Rodriguez J, Meylan F, Handon R, Hayes ET, Anderson SM et al (2016) Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4. Nat Commun 7:10857
49. von Bonin A, Rausch A, Mengel A, Hitchcock M, Kruger M et al (2011) Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases. Exp Dermatol 20(1):41–47
50. Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S et al (2016) Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 138(2):336–349
51. Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M et al (2011) An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 12(11):1071–1077
52. Simpson, E.L., T. Bieber, E. Guttman-Yassky, L.A. Beck, A. Blauvelt, et al., Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med, 2016.
53. Singh TP, Schon MP, Wallbrecht K, Gruber-Wackernagel A, Wang XJ et al (2013) Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One 8(1):e51752
54. Liu J, Harberts E, Tammaro A, Girardi N, Filler RB et al (2014) IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol 134(7):1903–1911
55. Gutin L, Tammaro A, Fishelevich R, Gaspari AA (2016) Elevation of IL-9 in extreme patch test reactions suggests it is an inflammatory mediator in allergic contact dermatitis. Dermatitis 27(1):35–36
56. Gulati N, Suarez-Farinas M, Fuentes-Duculan J, Gilleaudeau P, Sullivan-Whalen M et al (2014) Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights. J Invest Dermatol 134(10):2531–2540
57. Coulter EM, Jenkinson C, Farrell J, Lavergne SN, Pease C et al (2010) Measurement of CD4+ and CD8+ T-lymphocyte cytokine secretion and gene expression changes in p-phenylenediamine allergic patients and tolerant individuals. J Invest Dermatol 130(1):161–174
58. Renauld JC, van der Lugt N, Vink A, van Roon M, Godfraind C et al (1994) Thymic lymphomas in interleukin 9 transgenic mice. Oncogene 9(5):1327–1332
59. Lv X, Feng L, Fang X, Jiang Y, Wang X (2013) Overexpression of IL-9 receptor in diffuse large B-cell lymphoma. Int J Clin Exp Pathol 6(5):911–916
60. Lv X, Feng L, Ge X, Lu K, Wang X (2016) Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma. J Exp Clin Cancer Res 35(1):106
61. Zhang J, Wang WD, Geng QR, Wang L, Chen XQ et al (2014) Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma. PLoS One 9(4):e94637
62. Lange K, Uckert W, Blankenstein T, Nadrowitz R, Bittner C et al (2003) Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice. Oncogene 22(4):517–527
63. Vieyra-Garcia PA, Wei T, Naym DG, Fredholm S, Fink-Puches R et al (2016) STAT3/5-dependent IL9 overexpression contributes to neoplastic cell survival in mycosis fungoides. Clin Cancer Res 22(13):3328–3339
64. Lu Y, Hong S, Li H, Park J, Hong B et al (2012) Th9 cells promote antitumor immune responses in vivo. J Clin Invest 122(11):4160–4171
65. Vegran F, Berger H, Boidot R, Mignot G, Bruchard M et al (2014) The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat Immunol 15(8):758–766
66. Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K et al (2015) The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat Immunol 16(10):1077–1084
67. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S (2011) Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J Rheumatol 38(10):2193–2197
68. Suarez-Farinas M, Ungar B, Noda S, Shroff A, Mansouri Y et al (2015) Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing. J Allergy Clin Immunol 136(5):1277–1287
69. Weber, B., C. Schlapbach, M. Stuck, H.U. Simon, L. Borradori, et al. 2016 Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planus. J Eur Acad Dermatol Venereol